ES2206296T3 - Derivados de tienopiranocarboxamida. - Google Patents

Derivados de tienopiranocarboxamida.

Info

Publication number
ES2206296T3
ES2206296T3 ES00958313T ES00958313T ES2206296T3 ES 2206296 T3 ES2206296 T3 ES 2206296T3 ES 00958313 T ES00958313 T ES 00958313T ES 00958313 T ES00958313 T ES 00958313T ES 2206296 T3 ES2206296 T3 ES 2206296T3
Authority
ES
Spain
Prior art keywords
group
alkoxy
polyfluoroalkoxy
tienopiranocarboxamida
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00958313T
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Rodolfo Testa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Application granted granted Critical
Publication of ES2206296T3 publication Critical patent/ES2206296T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuesto cuya fórmula general I es donde R representa un grupo arilo, cicloalquilo o polihaloalquilo, R1 representa un grupo alquilo, alcoxi, polifluoroalcoxi, hidroxi o trifluorometanosulfoniloxi, R2 y R3 representan independientemente un átomo de hidrógeno o halógeno, o un grupo alcoxi o polifluoroalcoxi, y n es 0, 1 ó 2, o que consiste en un N-óxido o en una sal farmacéuticamente aceptable de dicho compuesto.
ES00958313T 1999-07-30 2000-07-28 Derivados de tienopiranocarboxamida. Expired - Lifetime ES2206296T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001704A IT1313581B1 (it) 1999-07-30 1999-07-30 Derivati tienopirancarbossamidici.

Publications (1)

Publication Number Publication Date
ES2206296T3 true ES2206296T3 (es) 2004-05-16

Family

ID=11383457

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00958313T Expired - Lifetime ES2206296T3 (es) 1999-07-30 2000-07-28 Derivados de tienopiranocarboxamida.

Country Status (22)

Country Link
EP (1) EP1200445B1 (es)
JP (1) JP2003506379A (es)
KR (1) KR100705179B1 (es)
CN (1) CN1155602C (es)
AT (1) ATE250068T1 (es)
AU (1) AU759085B2 (es)
BR (1) BR0012871A (es)
CA (1) CA2378302A1 (es)
DE (1) DE60005368T2 (es)
DK (1) DK1200445T3 (es)
ES (1) ES2206296T3 (es)
HU (1) HUP0202106A3 (es)
IL (2) IL147441A0 (es)
IT (1) IT1313581B1 (es)
MX (1) MXPA02000820A (es)
NO (1) NO20020476L (es)
PL (1) PL198700B1 (es)
PT (1) PT1200445E (es)
RU (1) RU2225409C2 (es)
TW (1) TWI239958B (es)
WO (1) WO2001009140A1 (es)
ZA (1) ZA200200687B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30111A1 (es) * 2006-02-03 2007-04-30 Recordati Ireland Ltd Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida
EP2231152B1 (en) * 2008-01-24 2014-01-01 SignalRX Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors
PE20160286A1 (es) 2013-08-08 2016-05-22 Galapagos Nv DERIVADOS DE TIENO [2,3-c] PIRANO Y SUS COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE LA FIBROSIS QUISTICA
JP2020506904A (ja) * 2017-01-27 2020-03-05 シグナルアールエックス ファーマシューティカルズ，インコーポレイテッド キナーゼ、ブロモドメイン及びチェックポイント阻害剤としてのチエノピラノン及びフラノピラノン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
EP1000045A1 (en) * 1997-08-01 2000-05-17 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY 1,4-disubstituted piperazines

Also Published As

Publication number Publication date
IL147441A0 (en) 2002-08-14
HUP0202106A2 (en) 2002-10-28
DE60005368T2 (de) 2004-07-01
TWI239958B (en) 2005-09-21
CA2378302A1 (en) 2001-02-08
EP1200445A1 (en) 2002-05-02
HK1044763A1 (en) 2002-11-01
AU6988200A (en) 2001-02-19
ITMI991704A0 (it) 1999-07-30
DK1200445T3 (da) 2004-01-12
RU2225409C2 (ru) 2004-03-10
CN1155602C (zh) 2004-06-30
BR0012871A (pt) 2002-04-16
MXPA02000820A (es) 2004-03-19
IL147441A (en) 2007-06-03
HUP0202106A3 (en) 2004-12-28
KR100705179B1 (ko) 2007-04-06
PL363115A1 (en) 2004-11-15
ZA200200687B (en) 2002-10-30
IT1313581B1 (it) 2002-09-09
ITMI991704A1 (it) 2001-01-30
KR20020022785A (ko) 2002-03-27
DE60005368D1 (en) 2003-10-23
ATE250068T1 (de) 2003-10-15
JP2003506379A (ja) 2003-02-18
PL198700B1 (pl) 2008-07-31
AU759085B2 (en) 2003-04-03
PT1200445E (pt) 2004-02-27
NO20020476D0 (no) 2002-01-29
NO20020476L (no) 2002-01-29
WO2001009140A1 (en) 2001-02-08
CN1365363A (zh) 2002-08-21
EP1200445B1 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
LU88749I2 (fr) TACRINE et ses dérivés pharmaceutiquement acceptables (COGNEX)
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
BR9608040A (pt) Composto pentacíclico
MX9701685A (es) Nuevos derivados de bencimidazol que tienen la actividad de inhibicion de la fosfodiestearasa cgmp.
NO20022125L (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
NO934792L (no) Xantinderivater
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
CO4990932A1 (es) Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion
ATE384722T1 (de) Alkoxypyridinderivate
NO20022232L (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
DE69725585D1 (de) Phenylalkylcarbonsäure-derivate
ATE513821T1 (de) Thiadiazolin-derivate zur behandlung von krebs
DK0947504T3 (da) 16-en-vitamin D-derivater
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
DE69616240D1 (de) 1,2-Dioxetan-Derivate als Wirkstoffe der Chemolumineszenz
TW350838B (en) Quinoline derivatives
ES2206296T3 (es) Derivados de tienopiranocarboxamida.
ATE215555T1 (de) 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
DK369289A (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
NO20002967L (no) Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor
BR9812928B1 (pt) derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica.
TW200510350A (en) Sulfonamide derivatives having isoxazole ring